Who Holds AN2 Therapeutics, Inc. (ANTX)? 66 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 66 holders, $119 million in total.
Largest holders
The 66 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Vivo Capital, LLC | 3,153,640 | $15 million | +0% | 13F |
| Commodore Capital LP | 2,933,680 | $14 million | +26% | 13F |
| MILLENNIUM MANAGEMENT LLC | 2,318,692 | $11 million | +4% | 13F |
| BlackRock, Inc. | 1,665,494 | $8 million | +422% | 13F |
| Spruce Street Capital LP | 1,661,073 | $8 million | +0% | 13F |
| Almitas Capital LLC | 1,469,129 | $7 million | -1% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,238,705 | $6 million | +23% | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $5 million | +0% | 13F |
| CITADEL ADVISORS LLC | 951,997 | $5 million | +513% | 13F |
| Boxer Capital Management, LLC | 749,035 | $4 million | +0% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 697,806 | $3 million | +144% | 13F |
| SummitTX Capital, L.P. | 597,453 | $3 million | New | 13F |
| Balyasny Asset Management L.P. | 556,027 | $3 million | New | 13F |
| Stonepine Capital Management, LLC | 551,692 | $3 million | -23% | 13F |
| AMERIPRISE FINANCIAL INC | 537,064 | $3 million | -23% | 13F |
| Sio Capital Management, LLC | 529,933 | $3 million | -19% | 13F |
| Ally Bridge Group (NY) LLC | 526,315 | $3 million | +0% | 13F |
| Prosight Management, LP | 474,638 | $2 million | -8% | 13F |
| Woodline Partners LP | 459,805 | $2 million | -54% | 13F |
| STATE STREET CORP | 311,602 | $2 million | +170% | 13F |
| NORTHERN TRUST CORP | 214,921 | $1 million | +398% | 13F |
| Seven Fleet Capital Management LP | 208,946 | $1 million | +5% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 196,920 | $953,093 | +43% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 179,594 | $869,235 | New | 13F |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 167,446 | $810,438 | -44% | 13F |
| BANK OF AMERICA CORP /DE/ | 145,803 | $705,686 | -63% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 129,700 | $627,748 | -35% | 13F |
| GOLDMAN SACHS GROUP INC | 87,933 | $425,596 | New | 13F |
| DIMENSIONAL FUND ADVISORS LP | 76,045 | $368,058 | New | 13F |
| UBS Group AG | 74,086 | $358,576 | +21% | 13F |
| Walleye Capital LLC | 72,139 | $349,153 | New | 13F |
| Bank of New York Mellon Corp | 67,676 | $327,552 | New | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 64,220 | $310,825 | New | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 59,900 | $289,916 | +0% | 13F |
| ADAR1 Capital Management, LLC | 58,808 | $284,631 | +324% | 13F |
| MORGAN STANLEY | 49,379 | $238,995 | -79% | 13F |
| CAPTRUST FINANCIAL ADVISORS | 40,165 | $194,399 | +0% | 13F |
| Velan Capital Investment Management LP | 40,000 | $193,600 | New | 13F |
| Nuveen, LLC | 35,333 | $171,012 | New | 13F |
| DEUTSCHE BANK AG\ | 25,838 | $125,056 | New | 13F |
| RHUMBLINE ADVISERS | 24,342 | $117,810 | New | 13F |
| WELLS FARGO & COMPANY/MN | 22,389 | $108,363 | New | 13F |
| TWO SIGMA INVESTMENTS, LP | 15,913 | $77,019 | New | 13F |
| Invesco Ltd. | 13,839 | $66,981 | New | 13F |
| LPL Financial LLC | 12,350 | $59,774 | New | 13F |
| CITIGROUP INC | 12,267 | $59,373 | -36% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 12,186 | $58,980 | New | 13F |
| JPMORGAN CHASE & CO | 10,971 | $55,184 | New | 13F |
| Bronte Capital Management Pty Ltd. | 10,895 | $52,732 | New | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 10,185 | $49,295 | -66% | 13F |
| Police & Firemen's Retirement System of New Jersey | 8,615 | $41,697 | New | 13F |
| Vanguard Global Advisers, LLC | 7,334 | $35,497 | +0% | 13F |
| BARCLAYS PLC | 5,491 | $26,577 | +1273% | 13F |
| NEW YORK STATE COMMON RETIREMENT FUND | 5,000 | $24,200 | New | 13F |
| Legal & General Group Plc | 2,576 | $12,429 | New | 13F |
| Ameritas Investment Partners, Inc. | 2,402 | $11,626 | New | 13F |
| Russell Investments Group, Ltd. | 2,112 | $10,222 | New | 13F |
| Tower Research Capital LLC (TRC) | 1,807 | $8,746 | +215% | 13F |
| ROYAL BANK OF CANADA | 938 | $5,000 | New | 13F |
| Sterling Capital Management LLC | 484 | $2,343 | New | 13F |
| FEDERATED HERMES, INC. | 449 | $2,173 | -95% | 13F |
| OSAIC HOLDINGS, INC. | 300 | $1,452 | +0% | 13F |
| Caitong International Asset Management Co., Ltd | 274 | $1,326 | -89% | 13F |
| SBI Securities Co., Ltd. | 201 | $973 | +0% | 13F |
| FMR LLC | 61 | $295 | New | 13F |
| PRICE T ROWE ASSOCIATES INC /MD/ | 22,022 | $107 | New | 13F |
Questions and answers
- How many institutions hold AN2 Therapeutics, Inc.?
- 66 managers reported AN2 Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 52 the quarter before.
- Who is the largest institutional holder of AN2 Therapeutics, Inc.?
- Vivo Capital, LLC, with 3,153,640 shares worth $15 million on its 13F for Q2 2026.
- How many institutions bought or sold out of AN2 Therapeutics, Inc. in Q2 2026?
- 28 managers reported a new position and 14 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds AN2 Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/an2-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.